Teladoc Reports $13.7B Loss for 2022, Just Two Years after Livongo Acquisition

Mar 20, 2023 | Laboratory Mergers and Acquisitions, Laboratory News, Laboratory Resources, Laboratory Sales and Marketing, Laboratory Testing, Precision Medicine

Loss could indicate an industrywide slowdown in digital health adoption and suggests medical laboratories will want to continue developing a virtual care strategy Only two years after Teladoc Health (NYSE:TDOC) completed acquisition of Livongo, a data-based health coaching company, the virtual healthcare provider reported a 2022 net loss of $13.7 billion, a company press release announced. The loss, which has been described as “historic,” is “mostly from a write-off related to the plummeting...
;